Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Alimera Sciences, Inc.

ALIMNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$5.54
$-0.01(-0.18%)
U.S. Market opens in 13h 56m

Alimera Sciences, Inc. (ALIM) Stock Overview

Explore Alimera Sciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap301.3M
P/E Ratio-7.03
EPS (TTM)$1.05
ROE-1.59%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$4.34

ALIM Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Alimera Sciences, Inc. (ALIM) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $4.34.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -7.03 and a market capitalization of 301.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
-1.07%
6-Month Change
57.39%
Year-to-Date (YTD) Change
35.78%
1-Year Change
110.65%
3-Year Change
27.06%
5-Year Change
-5.20%
All-Time (Max) Change
-96.64%

Contact Information

678 990 5740
6310 Town Square, Alpharetta, GA, 30005

Company Facts

1,540 Employees
IPO DateNov 4, 2019
CountryUS

Frequently Asked Questions